Cardiac Imaging: Page 154

Speedy Web tool guides echocardiography appropriateness
By Eric Barnes
A new Web-based application takes less than a minute to tell physicians if the transthoracic echocardiography test they're pondering is appropriate for the patient. A feasibility study presented at the recent American Society of Echocardiography meeting showed that it can potentially save doctors and patients a lot of time, money, and heartache.
June 20, 2010
2010 06 18 12 52 40 30 Ward screenshot
CIHI: Isotope shortage reduced nuke exams
By AuntMinnie.com staff writers
The Canadian Institute for Health Information (CIHI) has reported that the medical isotope shortage resulted in a 22% decline in nuclear medicine exams for cardiac, bone, and lung diagnostic tests on Canadian patients in October 2009 compared to October 2008.
June 17, 2010
Lantheus touts Definity safety data
By AuntMinnie.com staff writers
Lantheus Medical Imaging said that new data from a phase IV safety study of its Definity echocardiography contrast agent have added further validation to the agent's safety profile.
June 15, 2010
Bracco reports cardiac PET growth
By AuntMinnie.com staff writers
Contrast agent developer Bracco Diagnostics said that the number of customers using its CardioGen-82 cardiac PET myocardial perfusion imaging tracer has increased by 46% in comparison with June of 2009.
June 15, 2010
Siemens upgrades Acuson SC2000
By AuntMinnie.com staff writers
Siemens Healthcare has released an upgraded version of its Acuson SC2000 volume imaging ultrasound system this week at the annual American Society of Echocardiography scientific sessions in San Diego.
June 14, 2010
Lantheus' F-18 PET agent shows good dosing ratio
By AuntMinnie.com staff writers
Preliminary phase II data suggest the uptake properties of Lantheus Medical Imaging's investigational PET agent flurpiridaz F-18 injection allow for a relatively low dosing ratio and a delay of 30 to 60 minutes between rest and stress injections, depending on the mode of stress used.
June 10, 2010
F-18 NaF PET/CT can help with atherosclerotic plaque detection
By Wayne Forrest
German researchers have found that F-18 sodium fluoride (F-18 NaF) PET/CT may provide "relevant information about the morphologic and functional properties of calcified plaque," according to a study published in the June issue of the Journal of Nuclear Medicine.
June 10, 2010
2010 06 10 14 47 29 370 Ct Pet Images Thumb
Lantheus touts results for PET agent at SNM
By AuntMinnie.com staff writers
Lantheus Medical Imaging is highlighting clinical data for a new PET radiopharmaceutical for imaging heart failure at this week's SNM meeting in Salt Lake City.
June 7, 2010
Lantheus reports F-18 cardiac PET findings
By AuntMinnie.com staff writers
Lantheus Medical Imaging said that preliminary data presented today at the annual SNM meeting indicate positive results with its investigational flurpiridaz F-18 cardiac PET imaging agent.
June 6, 2010
PET/CT may improve therapy for congestive heart failure patients
By Wayne Forrest
SALT LAKE CITY - German researchers have found that FDG-PET/CT can help determine when cardiac resynchronization therapy is ineffective, and it can identify risk factors that could alter the course of treatment for patients with congestive heart failure, according to a study presented Sunday at the SNM meeting.
June 6, 2010
2010 06 07 09 55 30 347 Snm Bug 2010
Cardiac model favors treadmill then CTA for low-risk patients
By Eric Barnes
A new cost-effectiveness model gives surprising prominence to the exercise treadmill test for evaluating patients with suspected coronary artery disease. In fact, treadmill plus imaging -- especially coronary CT angiography (CTA) for low-risk patients -- was more cost-effective than any imaging modality alone.
June 6, 2010
2010 05 28 14 50 17 874 Min 20percent 450
Philips begins selling PET/CT unit in U.S.
By AuntMinnie.com staff writers
Philips Healthcare has begun shipping its Gemini LXL PET/CT scanner in North America.
June 3, 2010
Previous Page
Page 154 of 322
Next Page